The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3
The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare reported estimates from different years. Models were developed for 15 countries to quantify and characterize the viraemic population and forecast the ch...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , |
| التنسيق: | article |
| منشور في: |
2015
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/5211 http://dx.doi.org/10.1111/jvh.12476 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://onlinelibrary.wiley.com/doi/10.1111/jvh.12476/full |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513465398329344 |
|---|---|
| author | Mokhbat, J. E. |
| author2 | Sibley, A. Han, K. H. Abourached, A. Lesmana, L. A. Makara, M. Jafri, W. Salupere, R. Assiri, A. M |
| author2_role | author author author author author author author author |
| author_facet | Mokhbat, J. E. Sibley, A. Han, K. H. Abourached, A. Lesmana, L. A. Makara, M. Jafri, W. Salupere, R. Assiri, A. M |
| author_role | author |
| dc.creator.none.fl_str_mv | Mokhbat, J. E. Sibley, A. Han, K. H. Abourached, A. Lesmana, L. A. Makara, M. Jafri, W. Salupere, R. Assiri, A. M |
| dc.date.none.fl_str_mv | 2015 2017-02-10T13:54:06Z 2017-02-10T13:54:06Z 2017-02-10 |
| dc.identifier.none.fl_str_mv | 1352-0504 http://hdl.handle.net/10725/5211 http://dx.doi.org/10.1111/jvh.12476 Sibley, A., Han, K. H., Abourached, A., Lesmana, L. A., Makara, M., Jafri, W., ... & Abbas, Z. (2015). The present and future disease burden of hepatitis C virus infections with today's treatment paradigm–volume 3. Journal of viral hepatitis, 22(S4), 21-41. http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://onlinelibrary.wiley.com/doi/10.1111/jvh.12476/full |
| dc.language.none.fl_str_mv | en |
| dc.relation.none.fl_str_mv | Journal of Viral Hepatitis |
| dc.rights.*.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.title.none.fl_str_mv | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 |
| dc.type.none.fl_str_mv | Article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/article |
| description | The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare reported estimates from different years. Models were developed for 15 countries to quantify and characterize the viraemic population and forecast the changes in the infected population and the corresponding disease burden from 2014 to 2030. With the exception of Iceland, Iran, Latvia and Pakistan, the total number of viraemic HCV infections is expected to decline from 2014 to 2030, but the associated morbidity and mortality are expected to increase in all countries except for Japan and South Korea. In the latter two countries, mortality due to an ageing population will drive down prevalence, morbidity and mortality. On the other hand, both countries have already experienced a rapid increase in HCV-related mortality and morbidity. HCV-related morbidity and mortality are projected to increase between 2014 and 2030 in all other countries as result of an ageing HCV-infected population. Thus, although the total number of HCV countries is expected to decline in most countries studied, the associated disease burden is expected to increase. The current treatment paradigm is inadequate if large reductions in HCV-related morbidity and mortality are to be achieved. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | LAURepo_537212ac68461564961626c040aaf056 |
| identifier_str_mv | 1352-0504 Sibley, A., Han, K. H., Abourached, A., Lesmana, L. A., Makara, M., Jafri, W., ... & Abbas, Z. (2015). The present and future disease burden of hepatitis C virus infections with today's treatment paradigm–volume 3. Journal of viral hepatitis, 22(S4), 21-41. |
| language_invalid_str_mv | en |
| network_acronym_str | LAURepo |
| network_name_str | Lebanese American University repository |
| oai_identifier_str | oai:laur.lau.edu.lb:10725/5211 |
| publishDate | 2015 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| spelling | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3Mokhbat, J. E.Sibley, A.Han, K. H.Abourached, A.Lesmana, L. A.Makara, M.Jafri, W.Salupere, R.Assiri, A. MThe total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare reported estimates from different years. Models were developed for 15 countries to quantify and characterize the viraemic population and forecast the changes in the infected population and the corresponding disease burden from 2014 to 2030. With the exception of Iceland, Iran, Latvia and Pakistan, the total number of viraemic HCV infections is expected to decline from 2014 to 2030, but the associated morbidity and mortality are expected to increase in all countries except for Japan and South Korea. In the latter two countries, mortality due to an ageing population will drive down prevalence, morbidity and mortality. On the other hand, both countries have already experienced a rapid increase in HCV-related mortality and morbidity. HCV-related morbidity and mortality are projected to increase between 2014 and 2030 in all other countries as result of an ageing HCV-infected population. Thus, although the total number of HCV countries is expected to decline in most countries studied, the associated disease burden is expected to increase. The current treatment paradigm is inadequate if large reductions in HCV-related morbidity and mortality are to be achieved.PublishedN/A2017-02-10T13:54:06Z2017-02-10T13:54:06Z20152017-02-10Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1352-0504http://hdl.handle.net/10725/5211http://dx.doi.org/10.1111/jvh.12476Sibley, A., Han, K. H., Abourached, A., Lesmana, L. A., Makara, M., Jafri, W., ... & Abbas, Z. (2015). The present and future disease burden of hepatitis C virus infections with today's treatment paradigm–volume 3. Journal of viral hepatitis, 22(S4), 21-41.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://onlinelibrary.wiley.com/doi/10.1111/jvh.12476/fullenJournal of Viral Hepatitisinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/52112021-03-19T10:00:56Z |
| spellingShingle | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 Mokhbat, J. E. |
| status_str | publishedVersion |
| title | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 |
| title_full | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 |
| title_fullStr | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 |
| title_full_unstemmed | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 |
| title_short | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 |
| title_sort | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3 |
| url | http://hdl.handle.net/10725/5211 http://dx.doi.org/10.1111/jvh.12476 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://onlinelibrary.wiley.com/doi/10.1111/jvh.12476/full |